Search

Search Results

• Metformin as a medicine decreasing cardiovascular risk in patients suffering from type 2 diabetes mellitus

  Małgorzata Wieteska, Agnieszka Kaczyńska, Dominik Maj, Paweł Stanicki, Aleksandra Chałupnik, Piotr Wójcik

  105-111

  2020-08-04
• E-cigarettes, is this alternative safe?

  Małgorzata Romaniuk, Konrad Suswał, Mateusz Komisarczuk, Weronika Tuszyńska, Karol Krupa, Wojciech Zygmunt, Janusz Milanowski

  313-321

  2020-08-22
• Cardiovascular Risks of Methylphenidate in Children with ADHD

  Adrianna Czachor, Elwira Servaas, Alicja Kotula, Mateusz Haber, Olga Grelewicz, Natalia Kucy, Adam Juśkiewicz, Paula Kula

  55139

  2024-10-08
• Venlafaxine and the Cardiovascular System: A Review of Hemodynamic Changes, Arrhythmia Risk, and Drug Interactions

  Klaudia Kozyra, Sylwia Kozieł-Kwit, Filip Skowierzak, Bartłomiej Lisik, Aleksandra Sado, Mariusz Wręczycki, Kacper Sawczuk, Aleksandra Simlat, Wiktoria Rogowska, Krzysztof Szada-Borzyszkowski

  69393

  2026-03-11
• Bempedoic Acid: A Novel Approach in Managing Dyslipidemia and Reducing Cardiovascular Risk

  Łukasz Wołowiec, Małgorzata Pellowska, Michał Janiak, Lidia Wydeheft, Grzegorz Grześk, Walery Zukow

  55416

  2024-09-28
• RNA Interference Therapeutics in Cardiology: Focus on Zilebesiran and Olpasiran

  Katarzyna Skibicka, Tomasz Skibicki, Weronika Wesołowska, Jarosław Pietrzak

  65429

  2025-09-21
• Effect of red rice on the lipid profile and risk of cardiovascular diseases

  Michał Lazar, Karolina Miszczyk, Patrycja Maj, Natalia Sergiel, Agata Kania, Malwina Gonet, Karolina Włodarczyk-Cybulska, Piotr Mozer, Jakub Maternia, Aleksandra Serwik-Trandasir

  76-88

  2023-08-29
• GLP-1 Receptor Agonists: A New Hope in the Global Fight Against Obesity — Benefits and Health Risks

  Oskar Pastuszek, Konrad Borowski, Maja Radziwon, Emilia Bolesta-Okuniewska, Paweł Michalak, Aleksandra Marchwińska-Pancer, Katarzyna Kopeć, Julia Ceryn, Anna Wicher

  67433

  2026-01-11
• Evaluation of the effectiveness and safety of anti-obesity drugs - an update on the current state of knowledge on available and investigational drugs

  Katarzyna Cichoń, Małgorzata Chyćko, Julia Czarnota, Agata Kromer, Magdalena Alicja Zapała, Agnieszka Środoń, Joanna Wilk, Małgorzata Maria Cholewa, Agnieszka Gawryś, Monika Łapaj

  94-112

  2023-05-31
• Aspartame in the Diet: A Contribution to the Debate on Safety and Health Impact

  Milena Biernikiewicz, Julia Biernikiewicz, Anna Wilewska, Bartosz Pomirski, Agata Pomirska, Agnieszka Borowiec, Konstanty Alabrudziński, Kinga Borowiec, Paulina Kwaśniewska, Artur Hovsepyan

  56847

  2025-02-12
• Pioglitazone - the forgotten drug with multidirectional action

  Arkadiusz Aab, Julia Zarańska

  11-19

  2023-04-25
• Ocena skuteczności i bezpieczeństwa farmakoterapii inhibitorami aldosteronu w niewydolności serca = Evaluation of the efficacy and safety of pharmacotherapy using aldosterone antagonists in heart failure

  Agata Tarczykowska, Bartosz Kochański, Łukasz Wołowiec, Agnieszka Surowiec, Anna Plaskiewicz, Walery Zukow

  153-162

  2015-07-05
• Glucagon-like peptide 1 receptor agonists in obesity treatment - a literature review

  Aleksander Jentkiewicz, Esmail Haj Obeid, Jakub Ulrych, Jan Krupa, Maciej Malinowski, Michał Krasowski, Alicja Kalinowska, Wiktoria Pietras, Adrian Kozieł, Zofia Kurek

  57712

  2025-02-06
• New Pharmacologic Approaches in Hypertension: Baxdrostat and Zilebesiran with Insights from BaxHTN and KARDIA-3 Trials

  Katarzyna Skibicka, Tomasz Skibicki, Weronika Wesołowsla, Jarosław Pietrzak

  65430

  2025-09-21
• The wind of change – PCSK9 inhibitors in hypolipidemic treatment. The Polish perspective

  Natalia Ilnicka, Patrycja Zuziak, Maria Sadlik, Daria Matyja, Leila Abod

  134-150

  2023-09-07
• Metformin - An Antidiabetic Drug With Anti-aging, Cardioprotective And Potential Anti-cancer Properties

  Magdalena Jabłonowska, Paulina Grzeszczuk, Aleksandra Kaczmarek, Wojciech Kaczmarek, Magdalena Krakowiak

  66564

  2025-11-16
• Androgenetic alopecia - a literature review

  Zuzanna Czyżewicz, Wiktoria Zamirska, Nadia Hornig, Aleksandra Cieplak, Aleksandra Kołodziej, Melania Czyżewicz

  60223

  2025-06-05
• The Treatment of Depression in Patients with Heart Failure

  Dominika Bachurska, Jakub Marek, Oliwia Grygorczuk, Zuzanna Czach

  50064

  2024-04-18
• Evaluating the Efficacy and Safety of Baricitinib in Reducing COVID-19 Mortality: A Comprehensive Review of Clinical Evidence and Pharmacological Strategies

  Paulina Kwaśniewska, Patryk Graczyk, Anna Wilewska, Kinga Borowiec, Agnieszka Borowiec, Julia Biernikiewicz, Konstanty Alabrudziński, Milena Biernikiewicz, Bartosz Pomirski, Agata Pomirska

  56441

  2024-12-08
• Mirabegron: the review of current knowledge of safety and efficacy in the relief of overactive bladder symptoms

  Tomasz Aleksiewicz, Kamil Leis, Wojciech Świerczyński, Kacper Miętkiewicz, Katarzyna Litwin, Przemysław Gałązka

  424-437

  2018-08-25
• From VICTORIA to VICTOR: Where Vericiguat Fits in HFrEF Care

  Katarzyna Skibicka, Weronika Wesołowska, Albert Jaśniak, Robert Bujak

  65624

  2025-09-24
• Marathon Health Pitfalls: What Every Runner Needs to Know

  Daniel Gondko, Patrycja Dębiec, Jakub Roman, Nikodem Pietrzak

  51692

  2024-06-03
• Model of nursing care for patients with Brugada syndrome according to the international ICNP®

  Aleksandra Stosiek, Jowita Pryszcz, Dominik Budzyna-Dawidowski, Beata Jankowska-Polańska

  523-529

  2019-08-30
• Benefits and disadvantages of drinking different types of tea – awareness of people based on anonymous surveys

  Kinga Grużewska-Piotrowska, Monika Pająk, Joanna Hubka, Agnieszka Grużewska, Wojciech Wcisło

  35-63

  2023-08-29
• The Chronic antiplatelet therapy in prevetion of cardiovascular diseases (in population of elderly) from the perspective of oral health: Cardiologic safety versus complications risk. Influence of oral diseases on global health risk in elderly

  Marta Wychota, Jan Bieniasz, Konrad Dendys, Marcel Kazzi, Michał Puła

  114-126

  2023-07-25
• The impact of L-Arginine supplementation on disorders associated with obesity

  Justyna Żyga

  223-228

  2022-08-31
• SGLT2-Inhibitors - significant role in Heart Failure treatment

  Karol Wielgus, Piotr Bator, Maria Pawłowska, Karol Magiera, Krystian Rachwał, Maria Antos, Jan Ramian, Grzegorz Łyko

  49418

  2024-05-22
• Psoriatic arthritis - Tofacitinib as a new treatment

  Marta Skorupska, Magdalena Joanna Czeczotka, Martyna Magdalena Martka, Natalia Aleksandra Popławska, Justyna Śliz, Krzysztof Woźniak

  51686

  2024-06-03
• Mindfulness and Movement: Scientifically Exploring the Health Impacts of Yoga

  Martyna Kuśmierska, Jakub Kuśmierski, Izabela Janik, Anna Martyka, Przemysław Ujma

  206-220

  2024-04-11
• Intermittent fasting and its influence on health and sports results

  Maria Kowalczuk, Justyna Lipińska, Łukasz Lipiński, Izabela Kopeć

  11-25

  2024-02-05
• Glucagon-like peptide-1 receptor agonists as a Therapeutic Option for Antipsychotic-Induced Obesity: A Review of Current Evidence

  Natalia Gniaź, Aleksandra Górska, Wiktor Grela, Jagoda Niewiadomska, Daria Furtak, Dawid Tulej, Paulina Głogowska, Alicja Dziedzic, Dominika Marciniuk, Natalia Marko

  56672

  2024-12-07
• Tirzepatide – a new hope for type 2 diabetes mellitus and obesity management. A literature review.

  Izabela Stawicka, Izabela Orzołek, Jakub Jarmołowicz, Agata Boczar, Patryk Dryja

  55971

  2024-11-12
• Berberine in the treatment of polycystic ovary syndrome

  Łukasz Ochyra, Anna Łopuszyńska, Mateusz Pawlicki, Halina Piecewicz-Szczęsna

  309-314

  2022-04-30
• A Comprehensive Review on the Latest Insights into Cold Therapies and Their Impact on the Human Body, with a Focus on Neurophysiological Responses

  Karol Stachyrak, Anna Gregułą, Bartosz Mazur, Dawid Mika, Aleksandra Kłos, Kamila Turek, Maciej Lambach, Mateusz Pawlicki, Aleksandra Mazurek, Wiktoria Wilanowska

  154-175

  2024-02-12
• The impact of shift work and sleep deficiency on health

  Agnieszka Możdżyńska, Laura Wojtala, Weronika Pawlak, Weronika Pawłocik, Lena Musiał, Julia Szymańska, Ewa Grabowska, Kamil Kapłon, Anna Rymarz, Dominika Kojder

  11-18

  2023-05-09
• Health effects of energy drinks, facts and myths - literature review

  Michał Żuber, Paulina Dąbrowska, Karol Bochyński, Michał Dacka, Katarzyna Molenda, Konrad Białogłowski, Katarzyna Ciuba, Filip Borodziuk, Barbara Borodziuk, Kamila Giżewska

  11-25

  2024-02-16
• Essential fatty acid and analysis of their impact on the human body based on latest research

  Nina Taborska, Anna Martyka, Martyna Kubicka-Figiel, Przemysław Ujma

  166-178

  2024-01-09
• Resistance training in Obstructive Sleep Apnea: current evidence, limitations, and future directions

  Urszula Majda, Anna Maruszak, Magdalena Michalik, Magdalena Mida, Julia Kwiecień, Julia Stołtny, Magdalena Lisik, Witold Kimla, Justyna Goryczka, Natalia Hajok

  2026-03-11
• Semaglutide for the treatment of obesity

  Rafał Oleszczuk, Iga Kozińska, Jordi Gras-Ozimek, Urszula Kozińska, Anna Oleszczuk

  1111-1123

  2022-08-25
• The Impact of Marine Algae on Health and Physical Performance: A Literature Review

  Gabriela Sikora, Martyna Woźniak, Karolina Kutnik, Karolina Koguc, Karolina Kusibab, Michał Czechowski, Gabriela Skórska, Marcela Słomianny, Karolina Kolada

  66470

  2025-11-09
• Viloxazine: A New Non-Stimulant Treatment for Attention-Deficit/Hyperactivity Disorder (ADHD)

  Wiktoria Wilanowska, Anna Greguła, Karol Stachyrak, Dawid Mika, Aleksandra Kłos, Kamila Turek, Maciej Lambach, Mateusz Pawlicki, Aleksandra Mazurek, Bartosz Mazur

  71-85

  2024-02-09
• Do the benefits outweigh the risks? Potential dangers associated with long-term therapy of proton pump inhibitors

  Izabela Wolanin, Bartłomiej Zielonka, Barbara Dengler, Karolina Madej, Marta Wolanin, Bartłomiej Stachyra, Cezary Stawikowski, Aleksandra Osińska, Ilona Kowalczyk, Aleksandra Krasa

  63-80

  2023-05-04
• Glucagon-like peptide-1 (GLP-1) agonists in the treatment of obesity

  Magdalena Mazurek, Edyta Białowąs, Ewelina Dybała, Iwona Cuber, Artur Aghadi

  196-205

  2023-02-23